Fructose-1,6-bisphosphatase 1 suppresses PPARα-mediated gene transcription and non-small-cell lung cancer progression

被引:0
|
作者
Shi, Rongkai [1 ,2 ]
Tao, Jingjing [1 ,2 ]
Jiang, Xiaoming [1 ,2 ]
Li, Min [1 ,2 ]
Zhu, Rongxuan [1 ,2 ]
Luo, Shudi [1 ,2 ]
Lu, Zhimin [1 ,2 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Zhejiang Prov Key Lab Pancreat Dis,Inst Translat M, Hangzhou 310029, Zhejiang, Peoples R China
[2] Zhejiang Univ, Canc Ctr, Hangzhou 310029, Zhejiang, Peoples R China
来源
AMERICAN JOURNAL OF CANCER RESEARCH | 2023年 / 13卷 / 10期
基金
浙江省自然科学基金; 中国国家自然科学基金;
关键词
FBP1; non -small cell lung cancer (NSCLC); glutamine deprivation; phosphorylation; O-GlcNAcylation; prognostic biomarker; PROMOTES; PHOSPHORYLATION; EXPRESSION; KINASE; GROWTH; PGK1;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Rapidly growing tumors often encounter energy stress, such as glutamine deficiency. However, how nor-mal and tumor cells differentially respond to glutamine deficiency remains largely unclear. Here, we demonstrate that glutamine deprivation activates PERK, which phosphorylates FBP1 at S170 and induces nuclear accumulation of FBP1. Nuclear FBP1 inhibits PPAR alpha-mediated beta-oxidation gene transcription in normal lung epithelial cells. In contrast, highly expressed OGT in non-small cell lung cancer (NSCLC) cells promotes FBP1 O-GlcNAcylation, which abrogates FBP1 phosphorylation and enhances beta-oxidation gene transcription to support cell proliferation under glutamine deficiency. In addition, FBP1 pS170 is negatively correlated with OGT expression in human NSCLC specimens, and low expression of FBP1 pS170 is associated with poor prognosis in NSCLC patients. These findings highlight the differential regulation of FBP1 in normal and NSCLC cells under glutamine deprivation and underscore the potential to target nuclear FBP1 for NSCLC treatment.
引用
收藏
页码:4742 / +
页数:15
相关论文
共 50 条
  • [11] Status epilepticus due to fructose-1,6-bisphosphatase deficiency caused by FBP1 gene mutation
    Mei, Shiyue
    Ma, Chao
    Cheng, Yibing
    Qian, Suyun
    Jin, Zhipeng
    PEDIATRIC INVESTIGATION, 2019, 3 (02) : 122 - 126
  • [12] Status epilepticus due to fructose-1,6-bisphosphatase deficiency caused by FBP1 gene mutation
    Mei Shiyue
    Ma Chao
    Cheng Yibing
    Qian Suyun
    Jin Zhipeng
    儿科学研究(英文), 2019, 3 (02)
  • [13] Fructose-1,6-bisphosphatase 1 in cancer: Dual roles, mechanistic insights, and therapeutic potential - A comprehensive review
    Song, Qinghang
    Sui, Jiazhen
    Yang, Yuxuan
    Zhang, Huhu
    Ya, Li
    Yang, Lina
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 293
  • [14] HUMAN FRUCTOSE-1,6-BISPHOSPHATASE GENE (FBP1) - EXON-INTRON ORGANIZATION, LOCALIZATION TO CHROMOSOME BANDS 9Q22.2-Q22.3, AND MUTATION SCREENING IN SUBJECTS WITH FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY
    ELMAGHRABI, MR
    LANGE, AJ
    JIANG, W
    YAMAGATA, K
    STOFFEL, M
    TAKEDA, J
    FERNALD, AA
    LEBEAU, M
    BELL, GI
    BAKER, L
    PILKIS, SJ
    GENOMICS, 1995, 27 (03) : 520 - 525
  • [15] LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase
    Jie Zou
    Xiaoyun Zhu
    Dejuan Xiang
    Yanqiu Zhang
    Jie Li
    Zhigui Su
    Lingyi Kong
    Hao Zhang
    ActaPharmaceuticaSinicaB, 2021, 11 (06) : 1578 - 1591
  • [16] LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase
    Zou, Jie
    Zhu, Xiaoyun
    Xiang, Dejuan
    Zhang, Yanqiu
    Li, Jie
    Su, Zhigui
    Kong, Lingyi
    Zhang, Hao
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (06) : 1578 - 1591
  • [17] A novel variant in the FBP1 gene causes fructose-1,6-bisphosphatase deficiency through increased ubiquitination
    Liang, Xiaoyan
    Liu, Xiaoliang
    Li, Wenjing
    Zhang, Lu
    Zhang, Bijun
    Lai, Guangrui
    Zhao, Yanyan
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2023, 742
  • [18] Down-Regulation of Fructose-1,6-Bisphosphatase (FBP1) in Triple-Negative Breast Cancer
    Yoon, Esther
    Hennrick, Kenneth
    Mao, Yong
    Volyanskyy, Konstantin
    Dimitrova, Nevenka
    Fallon, John T.
    Zhang, Minhao
    LABORATORY INVESTIGATION, 2016, 96 : 79A - 79A
  • [19] Down-Regulation of Fructose-1,6-Bisphosphatase (FBP1) in Triple-Negative Breast Cancer
    Yoon, Esther
    Hennrick, Kenneth
    Mao, Yong
    Volyanskyy, Konstantin
    Dimitrova, Nevenka
    Fallon, John T.
    Zhong, Minhao
    MODERN PATHOLOGY, 2016, 29 : 79A - 79A
  • [20] Knockdown of CHPF suppresses cell progression of non-small-cell lung cancer
    Hou, Xiao-Ming
    Baloch, Zulqarnain
    Zheng, Zhan-Hong
    Zhang, Wen-Hui
    Feng, Ying
    Li, Duan-Duan
    Wu, Xin-An
    Yang, Shi-Hua
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 3275 - 3283